Clinical Trials List
2009-06-01 - 2014-12-31
Phase III
Terminated2
Study ended5
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 周宏學 Division of Obstetrics & Gynecology
- Min-Yu Chen Division of Obstetrics & Gynecology
- 周宏學 Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Hung-Cheng Lai Division of Obstetrics & Gynecology
- 張正昌 Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- 陳祈安 Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Keng-Fu Hsu Division of Obstetrics & Gynecology
- 鄭雅敏 Division of Obstetrics & Gynecology
- Yu-Fang Huang Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Yi-Jen Chen Division of Obstetrics & Gynecology
- Peng-Hui Wang Division of Obstetrics & Gynecology
- 吳華席 Division of Obstetrics & Gynecology
- 沈書慧 Division of Obstetrics & Gynecology
- Nae-Fang Twu Division of Obstetrics & Gynecology
- Chi-Mu Chuang Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Study ended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
900 participants
